{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:38:00Z","timestamp":1774975080078,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.mehy.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T02:15:25Z","timestamp":1551752125000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Male PCOS equivalent and nutritional restriction: Are we stepping forward?"],"prefix":"10.1016","volume":"126","author":[{"given":"Federica","family":"Di Guardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cecilia","family":"Cerana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisella","family":"D'urso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2019.03.003_b0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1472-6483(10)61114-5","article-title":"Genetics of polycystic ovarian syndrome","volume":"10","author":"Fratantonio","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"10.1016\/j.mehy.2019.03.003_b0010","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.mehy.2019.03.003_b0015","doi-asserted-by":"crossref","first-page":"6517313","DOI":"10.1155\/2016\/6517313","article-title":"Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions","volume":"2016","author":"Vitale","year":"2016","journal-title":"PPAR Res"},{"issue":"5","key":"10.1016\/j.mehy.2019.03.003_b0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.mehy.2019.03.003_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17070999","article-title":"Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives","volume":"17","author":"Lagan\u00e0","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2019.03.003_b0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000341682","article-title":"Genetics of polycystic ovary syndrome","volume":"40","author":"Barber","year":"2013","journal-title":"Front Hormone Res"},{"key":"10.1016\/j.mehy.2019.03.003_b0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.fertnstert.2016.03.029","article-title":"Increased antimullarian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome","volume":"106","author":"Torchen","year":"2016","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.mehy.2019.03.003_b0040","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/deu282","article-title":"Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.mehy.2019.03.003_b0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","article-title":"Evidence for a single gene effect causing polycystic ovaries and male pattern baldness","volume":"38","author":"Carey","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.mehy.2019.03.003_b0050","first-page":"1307","article-title":"Is there a male phenotype in polycystic ovary syndrome families?","volume":"13","author":"Legro","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mehy.2019.03.003_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930573","article-title":"What may be the markers of the male equivalent of polycystic ovary syndrome?","volume":"53","author":"Duskov\u00e1","year":"2004","journal-title":"Physiol Res"},{"issue":"1","key":"10.1016\/j.mehy.2019.03.003_b0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000293493","article-title":"Familial clustering in the Polycystic Ovarian syndrome","volume":"28","author":"Lunde","year":"1989","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"10.1016\/j.mehy.2019.03.003_b0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","article-title":"Hyperinsulinemia is common in family members of women with polycystic ovary syndrome","volume":"66","author":"Norman","year":"1996","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.mehy.2019.03.003_b0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.mehy.2019.03.003_b0075","first-page":"707","article-title":"Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome","volume":"129","author":"Ben\u00edtez","year":"2001","journal-title":"Rev Med Chil"},{"issue":"9","key":"10.1016\/j.mehy.2019.03.003_b0080","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mehy.2019.03.003_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2016.08.026","article-title":"Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome","author":"Orio","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"8","key":"10.1016\/j.mehy.2019.03.003_b0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jama.1993.03500080046030","article-title":"A case-control study of baldness in relation to myocardial infarction in men","volume":"269","author":"Lesko","year":"1993","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mehy.2019.03.003_b0095","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/oxfordjournals.aje.a117722","article-title":"Baldness and coronary heart disease rates in men from the Framingham Study","volume":"142","author":"Herrera","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.mehy.2019.03.003_b0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a008797","article-title":"Baldness and ischemic heart disease in a national sample of men","volume":"143","author":"Ford","year":"1996","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.mehy.2019.03.003_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.160.2.165","article-title":"Male pattern baldness and coronary heart disease: the Physicians\u2019 Health Study","volume":"160","author":"Lotufo","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mehy.2019.03.003_b0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/cs1020151","article-title":"Sex steroids and insulin resistance","volume":"102","author":"Livingstone","year":"2002","journal-title":"Clin Sci"},{"issue":"9236","key":"10.1016\/j.mehy.2019.03.003_b0115","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(00)02763-X","article-title":"Early androgenetic alopecia as a marker of insulin resistance","volume":"356","author":"Matilainen","year":"2000","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.mehy.2019.03.003_b0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/2229-5178.137776","article-title":"Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"10.1016\/j.mehy.2019.03.003_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1684\/ejd.2010.1193","article-title":"The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia","volume":"21","author":"Mumcuoglu","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.mehy.2019.03.003_b0130","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mehy.2019.03.003_b0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/0974-7753.122961","article-title":"Hormonal profile in Indian men with premature androgenetic alopecia","volume":"5","author":"Narad","year":"2013","journal-title":"Int J Trichol"},{"issue":"4","key":"10.1016\/j.mehy.2019.03.003_b0140","first-page":"127","article-title":"Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?","volume":"39","author":"Starka","year":"2005","journal-title":"Endrocr Regul"},{"issue":"1","key":"10.1016\/j.mehy.2019.03.003_b0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2004-815723","article-title":"Hormonal profile of men with premature balding","volume":"112","author":"Starka","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.mehy.2019.03.003_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6189820","article-title":"Inositols in the treatment of insulin-mediated diseases","volume":"2016","author":"Muscogiuri","year":"2016","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.mehy.2019.03.003_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.mehy.2019.03.003_b0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2019.03.003_b0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mehy.2019.03.003_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ajcn\/84.1.77","article-title":"Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome","volume":"84","author":"Moran","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2019.03.003_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/541021","article-title":"Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in severely obese adolescents","volume":"2011","author":"Grulich-Henn","year":"2011","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.mehy.2019.03.003_b0180","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11883-014-0442-0","article-title":"Lifestyle interventions for cardiovascular disease risk reduction: a systematic review of the effects of diet composition, food provision, and treatment modality on weight loss","volume":"16","author":"Dutton","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.mehy.2019.03.003_b0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mehy.2019.03.003_b0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/bmc-2014-0038","article-title":"Longevity: epigenetic and biomolecular aspects","volume":"6","author":"Taormina","year":"2015","journal-title":"Biomol Concepts"},{"key":"10.1016\/j.mehy.2019.03.003_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.06.013","article-title":"Fasting as possible complementary approach for polycystic ovary syndrome: hope or hype?","volume":"105","author":"Chiofalo","year":"2017","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.03.003_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/j.1467-789X.2011.00873.x","article-title":"Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss?","volume":"12","author":"Varady","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.mehy.2019.03.003_b0205","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.1035720100","article-title":"Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake","volume":"100","author":"Anson","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2019.03.003_b0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.mehy.2019.03.003_b0215","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.43695","article-title":"Evidence-based and patient-oriented inositol treatment in polycystic ovary syndrome: changing the perspective of the disease","volume":"15","author":"Lagan\u00e0","year":"2017","journal-title":"Int J Endocrinol Metab."},{"issue":"11","key":"10.1016\/j.mehy.2019.03.003_b0220","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s12325-018-0810-1","article-title":"Polycystic ovary syndrome: implication for drug metabolism on assisted reproductive techniques-a literature review","volume":"35","author":"Reyes-Mu\u00f1oz","year":"2018","journal-title":"Adv Ther"},{"issue":"12","key":"10.1016\/j.mehy.2019.03.003_b0225","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/09513590.2012.685205","article-title":"Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients","volume":"28","author":"Genazzani","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"2018","key":"10.1016\/j.mehy.2019.03.003_b0230","first-page":"7234543","article-title":"Current management of polycystic ovary syndrome: from bench to bedside","volume":"14","author":"Lagan\u00e0","year":"2018","journal-title":"Int J Endocrinol."},{"issue":"18","key":"10.1016\/j.mehy.2019.03.003_b0235","first-page":"4243","article-title":"Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal","volume":"21","author":"Lagan\u00e0","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.mehy.2019.03.003_b0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.dsx.2012.09.006","article-title":"Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome","volume":"6","author":"Patra","year":"2012","journal-title":"Diabetes Metabolic Syndrome: Clin Res Rev"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719300532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719300532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:14:32Z","timestamp":1759691672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719300532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":48,"alternative-id":["S0306987719300532"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.03.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male PCOS equivalent and nutritional restriction: Are we stepping forward?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}